Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (32)

2024

  1. BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice

    Epilepsia Open

2023

  1. Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program

    Epilepsia Open, Vol. 8, Núm. 3, pp. 918-929

2022

  1. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

  2. MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice

    Diagnostics, Vol. 12, Núm. 1

  3. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy

    Epilepsy and Behavior, Vol. 137

2021

  1. 1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress

    Revista de Neurologia

  2. Document of revision and updating of medication overuse headache (MOH)

    Neurologia, Vol. 36, Núm. 3, pp. 229-240

  3. MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention

    Journal of Headache and Pain, Vol. 22, Núm. 1

  4. The impact of a digital platform on migraine patient-centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish

    Headache, Vol. 61, Núm. 9, pp. 1403-1410

2020

  1. Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study

    Journal of Neuro-Oncology, Vol. 148, Núm. 3, pp. 545-554

  2. Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine

    Neurologia, Vol. 35, Núm. 8, pp. 568-578

2019

  1. BRIVA-LIFE–A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

    Acta Neurologica Scandinavica, Vol. 139, Núm. 4, pp. 360-368

  2. Evidence and experience with onabotulinumtoxinA in chronic migraine: Recommendations for daily clinical practice

    Neurologia, Vol. 34, Núm. 6, pp. 408-417

2018

  1. Mitos y evidencias en el empleo de la toxina botulínica: Neurofarmacología y distonías

    Revista de Neurologia, Vol. 66, Núm. 5, pp. 163-172

2017

  1. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

    Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264

  2. Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study

    Epilepsy and Behavior, Vol. 73, pp. 173-179

  3. Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series

    Seizure, Vol. 48, pp. 53-56

2014

  1. Agonistas dopaminérgicos en la enfermedad de Parkinson

    Neurologia

  2. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

2013

  1. Advanced Parkinson's disease: Clinical characteristics and treatment (part 1)

    Neurologia, Vol. 28, Núm. 8, pp. 503-521